Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display

4006 - The effect of short-course neoadjuvant radiotherapy (5Gy ×5 fractions) on rectal tumor immune microenvironment


09 Oct 2016


Poster display


Xin Wang


Annals of Oncology (2016) 27 (6): 359-378. 10.1093/annonc/mdw378


X. Wang1, P. Shu1, Y. Wang2

Author affiliations

  • 1 Department Of Abdominal Oncology, West China Hospital, Huaxi, Sichuan University, 610041 - Chengdu/CN
  • 2 Thoracic Oncology, Cancer Center And State Key Laboratory Of Biotherapy, West China Hospital, West China Medical School, Sichuan University, 610041 - Chengdu/CN


Abstract 4006


Short-course neoadjuvant radiotherapy of 5Gy × 5 fractions is recommended to be a standard treatment for the patients with ressectable stage II/III rectal cancer. While the effect of radiotherapy of 5Gy × 5f on the tumor microenvironment is still unclear. The purpose of this study was to evaluate the interactions between radiotherapy of 5Gy × 5f and the tumor immune microenvironment.


The changes in the number of immune cells, the changes of P-STAT1, P-STAT3, MICA, KIR, PD-L1 and Gal-1 in tumor before and after radiotherapy were assessed in mouse CT26 rectal cancer model. The effects of radiotherapy of 5Gy × 3f and 5Gy × 5f on HCT116, RKO, SW480,174T, DLD-1 cell lines were also investigated. Furthermore, clinical samples of patients with rectal cancer were analyzed. The changes of T lymphocytes in blood and T lymphocytes and NK cells in tumor before and after radiotherapy were tested. The infiltration of CD8 + T lymphocyte in tumor was studied as well.


In CT26 models, the radiotherapy of 5Gy × 5f promoted CD4 + and CD8 + T lymphocyte infiltration (P


Radiotherapy of 5Gy × 5f could promote the infiltration of CD4 + and CD8 + T lymphocyte in local tumor, and enhance the anti-tumor effect of NK cells and T lymphocytes. Short-course neoadjuvant radiotherapy of 5Gy × 5f have immune stimulatory effects for rectal cancer.

Clinical trial identification

Legal entity responsible for the study



Chinese National Natural Science Foundation (NSFC 8120175).


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings